ARCHIVES

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

This article is from The Cancer Letter archive.

Vol. 31 No. 01 | January 7, 2005

Download PDF Visit The Full Archive

Related Articles

Niederhuber Leads AACI

November 2, 2001

Treatment Progress Since 1972 Provides Powerful Support For Continuing National Cancer Program

March 23, 1979

In the Cancer Centers: Margaret Kripke of M.D. Anderson to Retire in 2007.

June 16, 2006

Lasker Pushes NCI To Get Research Results Quicker, Into Practice Sooner

May 31, 1974

Satcher Calls For Wider Use Of Smoking Prevention Efforts.

September 29, 2000

In Brief: George Burton Retires After 23 Years At NCI; MDA Names Bodey Head Of Medical Specialists

February 20, 1987